How should I work up and manage chronic lymphadenopathy (enlarged lymph nodes persisting >4–6 weeks) in an otherwise healthy adult without acute infection?

Workup and Management of Chronic Lymphadenopathy in Adults

For chronic lymphadenopathy (>4–6 weeks) in an otherwise healthy adult, obtain a detailed history focusing on node characteristics, perform ultrasound imaging for nodes >15 mm, and proceed directly to excisional biopsy if lymphadenopathy persists beyond 4 weeks with concerning features or beyond 10 weeks regardless of features, as this significantly reduces diagnostic delay compared to sequential needle biopsies. 1, 2, 3

Initial Clinical Assessment

Document the following specific features:

• Node characteristics: Size (measure short-axis diameter), number, location (single chain vs. multiple chains), consistency (soft vs. hard), mobility (mobile vs. fixed/matted), and tenderness 1, 2
• Duration: Nodes persisting >4 weeks warrant investigation; those >10 weeks require tissue diagnosis 2, 4, 5
• Constitutional symptoms: Fever, drenching night sweats, unintentional weight loss >10% body weight (B symptoms suggest lymphoma and mandate PET/CT) 1, 6, 2
• Exposures: Occupation, travel history, animal contacts, sexual history, recent vaccinations, medication use, and drug use 2
• Primary site search: Examine genitalia, perineum, lower extremities, perianal region, and skin for potential primary malignancy 1

Risk Stratification by Node Features

High-Risk Features Requiring Immediate Biopsy:

• Size: >15 mm short-axis diameter (nodes ≤15 mm are consistently benign) 1, 6, 7
• Location: Supraclavicular or epitrochlear nodes (high malignancy risk) 2
• Morphology: Hard consistency, matted/fused nodes, round (not oval) shape, loss of fatty hilum 1, 6, 2
• Systemic: Presence of B symptoms, hepatosplenomegaly, or progressive enlargement 6, 2

Lower-Risk Features:

• Nodes ≤15 mm with oval shape and preserved fatty hilum on ultrasound require no further imaging 6, 7
• Soft, mobile, tender nodes in the setting of identifiable local infection may be observed 2

Diagnostic Algorithm

Step 1: Ultrasound Evaluation

Perform ultrasound for all nodes >15 mm to assess:

• Shape (oval vs. round), border regularity, internal architecture (fatty hilum presence), echogenicity (homogeneous vs. heterogeneous), and presence of necrosis 1, 6, 7
• Ultrasound with fine-needle aspiration increases diagnostic yield for metastases >2 mm 8

Step 2: Cross-Sectional Imaging

Obtain CT abdomen/pelvis with IV contrast when:

• Nodes are borderline enlarged or difficult to assess clinically 1
• Concern exists for deeper pelvic/retroperitoneal involvement 1
• Nodes ≥4 cm (assess extent before biopsy) 1
• B symptoms present (use PET/CT instead) 1, 6

Step 3: Laboratory Studies

Order the following for persistent lymphadenopathy:

• Complete blood count, C-reactive protein, erythrocyte sedimentation rate 2
• Tuberculosis testing (especially for cervical nodes) 2, 4
• HIV testing, EBV serology if clinically indicated 6, 2

Step 4: Tissue Diagnosis

Fine-needle aspiration (FNA) is the initial diagnostic step for:

• Nodes <4 cm with sensitivity 91.7% and specificity 98.2% for malignancy 1
• Suspected metastatic disease from known primary 1

Excisional biopsy is mandatory for:

• Lymphadenopathy persisting >4 weeks with concerning features or >10 weeks regardless 2, 4, 5
• Negative FNA with continued clinical suspicion (confirm with excisional biopsy) 1
• Suspected lymphoma (entire node required for accurate histologic diagnosis) 5, 3
• Direct surgical referral reduces investigation time from 3 months to 1.25 months compared to sequential needle biopsies 3

Management Based on Etiology

If FNA/Biopsy Positive for Malignancy:

• Initiate immediate oncologic management based on primary malignancy identified 1
• For lymphoma, proceed with staging examinations (PET/CT, bone marrow biopsy) 5

If FNA Negative but Clinical Suspicion Remains:

• Perform excisional biopsy for definitive diagnosis 1
• Re-biopsy if nodes enlarge or new systemic symptoms develop 1

If Benign Reactive Changes:

• Most reactive lymphadenopathies resolve spontaneously within 10 weeks 9, 4
• Surveillance every 3 months for nodes that remain stable 1

Critical Pitfalls to Avoid

• Do not rely on size alone: Normal-sized nodes can harbor microscopic metastases; enlarged nodes may be hyperplastic 6, 7
• Do not delay excisional biopsy: Sequential needle biopsies significantly prolong time to diagnosis without improving accuracy 3
• Do not use antibiotics empirically unless bacterial lymphadenitis is clearly suspected with identifiable focus 2
• Never use corticosteroids before tissue diagnosis—they mask histologic features of lymphoma 2
• Do not assume all enlarged nodes are infectious: Reactive lymphadenopathies mistaken for lymphomas are among the most frequently misdiagnosed cancers 9

Special Considerations

For sexually active patients with tender unilateral inguinal lymphadenopathy, consider lymphogranuloma venereum and treat with doxycycline 100 mg orally twice daily for 21 days 1